Harib H. Ezaldein, MD; Jeffrey F. Scott, MD; Emily S. Yin, BS; et al.
free access
JAMA Dermatol. 2018;154(3):273-280. doi:10.1001/jamadermatol.2017.5757
This cross-sectional database study characterizes the postapproval changes to Class III dermatologic devices and evaluates inconsistencies in the use of the premarket approval pathway.
Khalaf Kridin, MD; Shira Zelber-Sagi, PhD; Doron Comaneshter, PhD; et al.
free access
has active quiz
JAMA Dermatol. 2018;154(3):281-285. doi:10.1001/jamadermatol.2017.5799
This population-based cross-sectional study estimates the association between pemphigus and 4 neurologic conditions using one of the largest cohorts of patients with pemphigus.
Megha M. Tollefson, MD; Holly K. Van Houten, BA; Dennis Asante, MS; et al.
free access
JAMA Dermatol. 2018;154(3):286-292. doi:10.1001/jamadermatol.2017.5417
This cohort study examines the risk ocomorbidities in children with and without psoriasis, after accounting for obesity.
Maja-Lisa Clausen, MD; Tove Agner, DMSc; Berit Lilje, PhD; et al.
free access
JAMA Dermatol. 2018;154(3):293-300. doi:10.1001/jamadermatol.2017.5440
This case-control study examines skin and nasal microbiome diversity and composition in patients with atopic dermatitis.
Muhammed Razmi T, MD, DNB; Ravinder Kumar, PhD; Seema Rani, MSc; et al.
free access
JAMA Dermatol. 2018;154(3):301-308. doi:10.1001/jamadermatol.2017.5795
This randomized clinical trial compares the effects of combined epidermal cell suspension and follicular cell suspension with those of epidermal cell suspension alone in treatment of vitiligo.
Tadashi Terui, MD, PhD; Satomi Kobayashi, MD, PhD; Yukari Okubo, MD, PhD; et al.
open access
JAMA Dermatol. 2018;154(3):309-316. doi:10.1001/jamadermatol.2017.5937
This randomized clinical trial evaluates the safety and efficacy of guselkumab compared with placebo for the treatment of palmoplantar pustulosis.
Severine Cao, BA; Ryan Karmouta, BA; David G. Li, BS; et al.
free access
JAMA Dermatol. 2018;154(3):317-322. doi:10.1001/jamadermatol.2017.5835
This cross-sectional study characterizes the current status and potential complications of opioid prescribing practices among dermatologists for Medicare beneficiaries.
Kumar S. Nadhan, BS; Mary Larijani, MD; James Abbott, MD; et al.
free access
JAMA Dermatol. 2018;154(3):323-329. doi:10.1001/jamadermatol.2017.5801
This medical record review assesses the prevalence and types of genital lesions observed in organ transplant recipients.
Schapoor Hessam, MD; Lisa Scholl, MD; Michael Sand, MD; et al.
free access
JAMA Dermatol. 2018;154(3):330-335. doi:10.1001/jamadermatol.2017.5890
This study examines the accuracy and clinical relevance of a newly developed scoring system for hidradenitis suppurativa severity.